FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Peregrine Reports Positive Data from Lung Cancer Trial

[ Price : $8.95]

Peregrine Pharmaceuticals reports favorable Phase 2b study data in patients with refractory non-small cell lung cancer that showed...

Qualitest Recalls Lot of Hydrocodone/Acetaminophen Tablets

[ Price : $8.95]

Qualitest issues a voluntary recall for one lot of hydrocodone bitartrate and acetaminophen tablets, USP 10 mg/500 mg due to the p...

Fiscal Cliff Could Divert FDA User Fees, Force Agency Layoffs

[ Price : $8.95]

FDA adds user fees to appropriated funds that could be at risk of sequestration if Congress and the White House dont step away fro...

Novartis Turning Corner on Lincoln, NE Plant Troubles

[ Price : $8.95]

Novartis appears to be making progress at its troubled Lincoln, NE manufacturing facility where it has recently resumed production...

FDA Clears Preventice BodyGuardian Remote Monitoring System

[ Price : $8.95]

FDA clears a Preventice, Inc. 510(k) for the BodyGuardian Remote Monitoring System for use in detecting and monitoring non-lethal ...

FDA Supply Chain Risk Assessments Aim to be Proactive: Official

[ Price : $8.95]

FDA associate director for global operations and policy Steve Solomon says globalization risks to the drug supply chain are causin...

FDA Posts July NADA, ANADA Approvals

[ Price : $8.95]

Federal Register Final rule: FDA amends the animal drug regulations to reflect July approval actions.

FDA Offers Guide on Pet Nutritional Product Labeling

[ Price : $8.95]

Federal Register Notice: FDA releases a draft compliance policy guide on the labeling and marketing of nutritional products for do...

Inside-FDA Scientific Research Agencys Hidden Success Story

[ Price : $8.95]

Attendees at FDAs third annual Science Writers Symposium are briefed on a variety of in-house research projectsexamples of a resea...

Merck Presents New Data on Insomnia Drug

[ Price : $8.95]

Merck presents new data from its Phase 3 safety and efficacy trial of its investigational insomnia drug suvorexant.